Published in Biochem Biophys Res Commun on March 19, 1971
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol (2009) 1.70
Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest (1975) 1.33
In vitro production of 1,25-dihydroxyvitamin D3 by rat placental tissue. Proc Natl Acad Sci U S A (1979) 1.17
Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog. J Clin Invest (1978) 1.14
Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. J Clin Invest (1976) 1.03
Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats. J Clin Invest (1973) 0.99
Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. J Clin Invest (1977) 0.99
Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats. J Clin Invest (1972) 0.99
Effects of cortisone administration on the metabolism and localization of 25-hydroxycholecalciferol in the rat. J Clin Invest (1973) 0.92
The role of phosphate in the action of vitamin D on the intestine. J Clin Invest (1977) 0.86
Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis. West J Med (1974) 0.85
Vitamin D: concerning the relationship between molecular topology and biological function. Proc Natl Acad Sci U S A (1974) 0.75
The role of the vitamin D endocrine system in health and disease. N Engl J Med (1989) 3.37
Vitamin D deficiency inhibits pancreatic secretion of insulin. Science (1980) 3.00
Structure-function relationships in the vitamin D endocrine system. Endocr Rev (1995) 2.54
Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of filipin with cholesterol. J Biol Chem (1972) 2.47
The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. J Biol Chem (1968) 2.29
Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med (1981) 2.00
gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun (1985) 1.97
Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr (1998) 1.96
The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev (1982) 1.92
1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1987) 1.89
Polyene antibiotic - sterol interaction. Adv Lipid Res (1976) 1.79
Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology (1986) 1.57
25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J Clin Endocrinol Metab (1987) 1.54
1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism. Lancet (1974) 1.49
Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man. N Engl J Med (1972) 1.39
An hydroxylapatite batch assay for the quantitation of 1alpha,25-dihydroxyvitamin D3-receptor complexes. Anal Biochem (1979) 1.38
1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J (1988) 1.37
Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest (1984) 1.34
Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest (1975) 1.33
1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J (2001) 1.29
Vitamin D: A cholecalciferol metabolite highly active in promoting intestinal calcium transport. Science (1971) 1.28
Vitamin D: metabolism and biological actions. Annu Rev Nutr (1984) 1.27
Studies on the mode of action of calciferol. XIII. Development of a radioimmunoassay for vitamin D-dependent chick intestinal calcium-binding protein and tissue distribution. Endocrinology (1979) 1.27
1,25-Dihydroxycholecalciferol--a hormonally active form of vitamin D. Recent Prog Horm Res (1974) 1.26
Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J Biol Chem (1994) 1.26
1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure. Ann Intern Med (1974) 1.25
Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J Clin Endocrinol Metab (1987) 1.24
Studies on the mechanism of action of calciferol. 3. Vitamin D-mediated increase of intestinal brush order alkaline phosphatase activity. Biochim Biophys Acta (1970) 1.20
Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells. Proc Natl Acad Sci U S A (2004) 1.20
Effects of 1 alpha,25-, 24R,25-, and 1 alpha,24R,25-hydroxylated metabolites of vitamin D3 on calcium and phosphate absorption by duodenum from intact and nephrectomized rats. Arch Biochem Biophys (1977) 1.19
Regulation of 25-hydroxyvitamin D3-1-hydroxylase in vivo. J Biol Chem (1974) 1.18
Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci U S A (1969) 1.18
Studies on the biological properties of polyene antibiotics: comparison of other polyenes with filipin in their ability to interact specifically with sterol. Biochim Biophys Acta (1972) 1.17
Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure. J Clin Endocrinol Metab (1986) 1.16
Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. J Biol Chem (1987) 1.15
The action of polyene antibiotics on lipid bilayer membranes in the presence of several cations and anions. Biochim Biophys Acta (1971) 1.15
Studies on the mechanism of action of calciferol VII. Localization of 1,25-dihydroxy-vitamin D3 in chick parathyroid glands. Biochem Biophys Res Commun (1975) 1.14
Monoclonal antibodies directed against the calcium binding protein Calbindin D-28k. Cell Calcium (1990) 1.12
Identification of cervical intraepithelial neoplasia (CIN) using UV-excited fluorescence and diffuse-reflectance tissue spectroscopy. Lasers Surg Med (2001) 1.12
Evidence for the biologically active form of cholecalciferol in the intestine. J Biol Chem (1970) 1.11
Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs. J Steroid Biochem Mol Biol (2005) 1.10
Effects and interactions of 24R,25(OH)2D3 and 1,25(OH)2D3 on bone. Am J Physiol (1980) 1.10
Immunohistochemical mapping of calcium-binding protein immunoreactivity in the rat central nervous system. Brain Res (1984) 1.08
Ontogeny of the calcium binding protein calbindin D-28k in the rat nervous system. Anat Embryol (Berl) (1987) 1.07
Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology (1987) 1.07
Vitamin D metabolism in hypoparathyroidism. J Clin Endocrinol Metab (1980) 1.07
Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J Clin Invest (1987) 1.07
1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice. Proc Natl Acad Sci U S A (1990) 1.07
Vitamin D--dependent calcium binding protein: immunocytochemical localization in chick kidney. Science (1981) 1.05
Studies on calciferol metabolism. 8. Evidence for a cytoplasmic receptor for 1,25-dihydroxy-vitamin D3 in the intestinal mucosa. J Biol Chem (1973) 1.05
Distinct conformational changes induced by 20-epi analogues of 1 alpha,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem (1995) 1.05
Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor. J Biol Chem (1997) 1.04
Nucleus basalis Meynert neurons contain the vitamin D-induced calcium-binding protein (Calbindin-D 28k). Anat Embryol (Berl) (1985) 1.04
Biological activity of the vitamin D metabolite 1,25-dihydroxycholecalciferol in chickens and rats. J Nutr (1972) 1.04
Biochemical properties of 1 alpha, 25-dihydroxyvitamin D receptors. J Steroid Biochem (1980) 1.04
Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. J Clin Invest (1976) 1.03
Vitamin D mediated synthesis of rapidly labeled RNA from intestinal mucosa. Biochem Biophys Res Commun (1966) 1.03
A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood (1996) 1.02
Studies on the mode of action of calciferol. XVIII. Evidence for a specific high affinity binding protein for 1,25 dihydroxyvitamin D3 in chick kidney and pancreas. Biochem Biophys Res Commun (1979) 1.01
Studies on calciferol metabolism. V. The occurrence and biological activity of 1,25-dihydroxy-vitamin D 3 in bone. J Biol Chem (1972) 1.01
Unoccupied 1,25-dihydroxyvitamin D3 receptors. Nuclear/cytosol ratio depends on ionic strength. J Biol Chem (1980) 1.01
Actinomycin D effect on lag in vitamin D-mediated calcium absorption in the chick. Am J Physiol (1966) 1.01
1,25-dihydroxycholecalciferol: identification of the proposed active form of vitamin D3 in the intestine. Science (1971) 1.00
Studies on calciferol metabolism. VII. The renal production of the biologically active form of vitamin D, 1,25-dihydroxycholecalciferol; species, tissue and subcellular distribution. J Clin Endocrinol Metab (1973) 0.99
Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats. J Clin Invest (1972) 0.99
Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3. Kidney Int (1976) 0.99
Photoprotection by 1alpha,25-dihydroxyvitamin D and analogs: further studies on mechanisms and implications for UV-damage. J Steroid Biochem Mol Biol (2010) 0.99
Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3. Endocrinology (1984) 0.98
Studies on the mode of action of calciferol. VI. Effect of 1,25-dihydroxy-vitamin D3 on RNA synthesis in the intestinal mucosa. Biochem Biophys Res Commun (1973) 0.98
Mannheim classification of nongenomically initiated (rapid) steroid action(s). J Clin Endocrinol Metab (2000) 0.98
The mode of action of vitamin D. Biol Rev Camb Philos Soc (1968) 0.97
1 alpha,25-Dihydroxyvitamin D3[1 alpha,25-(OH)2D3]-26,23-lactone inhibits 1,25-(OH)2D3-mediated fusion of mouse bone marrow mononuclear cells. Endocrinology (1988) 0.96
Stimulation by 1alpha,25(OH)2-vitamin D3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells. A structure-function study. J Biol Chem (1997) 0.95
Studies on calciferol metabolism. IV. Subcellular localization of 1,25-dihydroxy-vitamin D 3 in intestinal mucosa and correlation with increased calcium transport. J Biol Chem (1972) 0.95
Localization of the vitamin D-dependent calcium-binding protein in mammalian kidney. Am J Physiol (1982) 0.95
Cofactor requirements of thymine 7-hydroxylase. Biochim Biophys Acta (1967) 0.95
The acute effects of 1,25-dihydroxycholecalciferol on serum immunoreactive parathyroid hormone in the dog. Endocrinology (1979) 0.95
Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets. N Engl J Med (1973) 0.95
Characterization of the 1 alpha,25-dihydroxyvitamin D3 receptor from rat intestinal cytosol. J Biol Chem (1979) 0.95
Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization. Blood (1989) 0.94
Studies on the mode of action of calciferol. Subcellular localization of 1,25-dihydroxyvitamin D3 in chicken parathyroid glands. Arch Biochem Biophys (1977) 0.94
Studies on the mechanism of action of calciferol. II. Effects of the polyene antibiotic, filipin, on vitamin D-mediated calcium transport. J Biol Chem (1970) 0.94
1,25-Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally. J Clin Invest (1988) 0.94
Demonstration that the vitamin D metabolite 1,25(OH)2-vitamin D3 and not 24R,25(OH)2-vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes (1985) 0.94
Studies on the mechanism of action of calciferol. I. Basic parameters of vitamin D-mediated calcium transport. J Biol Chem (1970) 0.93
Biochemical properties of the 1 alpha, 25-dihydroxyvitamin D3 cytoplasmic receptors from human and chick parathyroid glands. Arch Biochem Biophys (1980) 0.93
Stimulation of phosphorylation of mitogen-activated protein kinase by 1alpha,25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: a structure-function study. Endocrinology (1998) 0.93
An insulinotropic effect of vitamin D analog with increasing intracellular Ca2+ concentration in pancreatic beta-cells through nongenomic signal transduction. Endocrinology (1999) 0.92
24R,25-dihydroxyvitamin D3: an essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology (1997) 0.92
In vivo relevance for photoprotection by the vitamin D rapid response pathway. J Steroid Biochem Mol Biol (2007) 0.92
The stereochemical configuration of the natural 1 alpha,25-dihydroxyvitamin D3-26,23-lactone. Arch Biochem Biophys (1985) 0.92